Cite
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study
MLA
Cortellini, A., et al. Smoking Status during First-Line Immunotherapy and Chemotherapy in NSCLC Patients: A Case-Control Matched Analysis from a Large Multicenter Study. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1415731895&authtype=sso&custid=ns315887.
APA
Cortellini, A., De Giglio, A., Cannita, K., Cortinovis, D., Cornelissen, R., Baldessari, C., Giusti, R., D’Argento, E., Grossi, F., Santoni, M., Catino, A., Berardi, R., Sforza, V., Rossi, G., Antonuzzo, L., Di Noia, V., Signorelli, D., Gelibter, A., Occhipinti, M., … Porzio G. (2021). Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Chicago
Cortellini, A, A De Giglio, K Cannita, D Cortinovis, R Cornelissen, C Baldessari, R Giusti, et al. 2021. “Smoking Status during First-Line Immunotherapy and Chemotherapy in NSCLC Patients: A Case-Control Matched Analysis from a Large Multicenter Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1415731895&authtype=sso&custid=ns315887.